QQ客服 官方微博 反馈留言

	Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial
	Su, Minghua; Duan, Zhongping; Hou, Jinlin; Jia, Jidong; Dou, Xiaoguang; Huang, Yan; Wu, Shanming; Xu, Min; Tang, Hong; Cheng, Jun
刊名	HEPATOLOGY
	2018
卷号	68
ISSN号	0270-9139
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3534174
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Su, Minghua,Duan, Zhongping,Hou, Jinlin,et al. Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial[J]. HEPATOLOGY,2018,68.
APA	Su, Minghua.,Duan, Zhongping.,Hou, Jinlin.,Jia, Jidong.,Dou, Xiaoguang.,...&Wei, Lai.(2018).Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial.HEPATOLOGY,68.
MLA	Su, Minghua,et al."Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial".HEPATOLOGY 68(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。